Workflow
Fusion Fuel Announces Over $2.7 Million in New Contracts and Substantial Utility Growth through Al Shola Gas
GlobeNewswire· 2025-05-22 12:00
DUBLIN, Ireland, May 22, 2025 (GLOBE NEWSWIRE) -- via IBN – Fusion Fuel Green PLC (Nasdaq: HTOO) ("Fusion Fuel" or the "Company"), a leading provider of full-service energy engineering, advisory, and utility solutions, today announced that its majority-owned operating subsidiary, Al Shola Al Modea Gas Distribution LLC (“Al Shola Gas”), has secured an estimated $2.7 million in new engineering contracts since the beginning of March 2025, and, since the beginning of January 2025, has added more than 1,800 resi ...
Evaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized cancer vaccine EVX-01
GlobeNewswire· 2025-05-22 12:00
Generation of additional clinical data allows for a more comprehensive assessment of the full potential of EVX-01, while strengthening the already strong clinical data packageWill provide insights into the durability of immune and clinical responses up to three yearsExtension phase enables exploration of EVX-01 as monotherapy, following initial combination with standard of careMinimal costs are associated with the extension as clinical sites are already running and the vaccines are producedThe trial remains ...
NevGold Announces Upsize to C$5.5M Brokered Private Placement Financing
GlobeNewswire· 2025-05-22 12:00
“NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.” VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce that, due to strong investor demand, it has agreed with Clarus Securities Inc. (the “Lead Agent”), as Lead Agent and sole bookrunner, on behalf of a syndicate of agents (the “Agents”), to increase the size of its previously announced $5,000 ...
Middlefield Banc Corp. Announces Retirement of Darryl E. Mast from Board of Directors
GlobeNewswire· 2025-05-22 12:00
MIDDLEFIELD, Ohio, May 22, 2025 (GLOBE NEWSWIRE) -- Middlefield Banc Corp. (NASDAQ: MBCN) today announced the retirement of Darryl E. Mast from its Board of Directors, effective May 14, 2025. Mr. Mast joined the Middlefield Banking Company’s Board of Directors in 2011 and has been a Director of Middlefield Banc Corp. since 2013. His leadership, insight, and expertise have been integral to the success of Middlefield Banc Corp. and The Middlefield Banking Company, and his contributions have left a lasting imp ...
Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
GlobeNewswire· 2025-05-22 12:00
NORWOOD, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will provide a corporate update and participate in one-on-one investor meetings at the Jefferies Global Healthcare Conference, to be held June 3-5, 2025 in New York, NY. Jefferies Global Healthcare ConferenceFormat: Presentation and one-on-one investor meetingsPresentation Date: June 4, 2025Presentation ...
Final terms for bonds to be listed 23rd May 2025
GlobeNewswire· 2025-05-22 11:55
To Nasdaq Copenhagen A/S 22nd May 2025 Announcement no. 44/2025Final terms for bonds to be listed 23rd May 2025On 23rd May 2025, Jyske Realkredit A/S will be listing new Covered Bonds (SDO). Final terms for the bonds are attached to this announcement. The full prospectus for the Bonds consist of the attached final terms and the previously disclosed ”Base Prospectus for the issue of Covered Bonds (SDO), Mortgage bonds (“RO”) and Mortgage Bonds (RO) and bonds issued pursuant to Section 15 of the Danish Mortg ...
KANZHUN LIMITED Announces Board Change
GlobeNewswire· 2025-05-22 11:51
BEIJING, May 22, 2025 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced that Ms. Hongyu Liu has been appointed as an independent non-executive director of the Company and a member of the nomination committee. Ms. Hongyu Liu, aged 52, is a financial expert with over 25 years of experience in the financial services industry. Ms. Liu currently serves as a managing director at Intermediate Capital Asia P ...
KANZHUN LIMITED to Hold Annual General Meeting on June 27, 2025
GlobeNewswire· 2025-05-22 11:50
BEIJING, May 22, 2025 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced that it will hold an annual general meeting of the Company’s shareholders (the “AGM”) at 3 p.m. Beijing time on June 27, 2025 at 21/F, GrandyVic Building, Taiyanggong Middle Road, Chaoyang District, Beijing, China for the purposes of considering and, if thought fit, passing with or without amendments, each of the proposed resolut ...
Launch of Long-Term Incentive Plan for executive management and key employees
GlobeNewswire· 2025-05-22 11:39
COMPANY ANNOUNCEMENT NO 28/2025 – MAY 22, 2025 Royal Unibrew A/S launches a new share-based Long-Term Incentive Plan (LTIP) for executive management and selected key employees for 2025. The plan is designed to align the interests of Royal Unibrew’s employees and shareholders and to retain employees. The new LTIP for 2025 has been approved by the Board of Directors. The LTIP is based on Performance Share Units (PSU) granted to each key employee. The PSUs are granted in 2025 for vesting on the date the Board ...
Quoin Pharmaceuticals Announces FDA Clearance to Initiate Second Pivotal Whole Body QRX003 Netherton Syndrome Clinical Study
GlobeNewswire· 2025-05-22 11:30
Study CL-QRX003-002 will test whole-body application of QRX003 in conjunction with off-label systemic therapy in approximately 12-15 subjects.Study CL-QRX003-002 complements first whole-body pivotal study, CL-QRX003-003, being led by Dr. Amy Paller at Northwestern University and supported by up to six international sites that are expected to open, where subjects are being tested with QRX003 as monotherapy. Combined data from Studies CL-QRX003-002 and CL-QRX003-003 is anticipated to provide QRX003 with the b ...